bucladesine has been researched along with Blood Clot in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Archipoff, G; Bartha, K; Beretz, A; Brisson, C; Cazenave, JP; de la Salle, C; Froget-Léon, C; Klein-Soyer, C | 1 |
Fukui, H; Kitagami, K; Matsumoto, M; Nakano, H; Nakayama, M; Okamoto, Y; Tsujii, T | 1 |
2 other study(ies) available for bucladesine and Blood Clot
Article | Year |
---|---|
Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities.
Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Base Sequence; Bucladesine; Cells, Cultured; Colforsin; Cyclic AMP; Dibutyryl Cyclic GMP; Endothelium, Vascular; Humans; Immunoenzyme Techniques; Kinetics; Microscopy, Immunoelectron; Molecular Sequence Data; Polymerase Chain Reaction; Receptors, Cell Surface; Receptors, Thrombin; RNA; RNA-Directed DNA Polymerase; Saphenous Vein; Thrombin; Thromboplastin; Thrombosis | 1993 |
[Effect of dibutyryl cyclic AMP in the treatment of hepatocellular carcinoma--intraarterial infusion therapy combined with anticancer agent for hepatocellular carcinoma with portal vein thrombosis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bucladesine; Carcinoma, Hepatocellular; Doxorubicin; Female; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Portal Vein; Thrombosis | 1992 |